EliA SmDP Immunoassay
Anti-Sm Antibody, Antigen And Control. 510(k) K183007, from Phadia AB (Uppsala, SE). Product code LKP, class 2.
As of Nov 21, 2026, K183007 is an FDA 510(k) held by Phadia AB, substantially equivalent on Dec 24, 2018 after 54 days, with no recalls tied to it in FDA's recall database.
- Review time: 54 days
- Recalls: 0
EliA SmDP is intended for the in vitro semi-quantitative measurement of IgG antibodies directed to Sm in human serum and EDTA-plasma to aid in the clinical diagnosis of systemic lupus erythematosus (SLE) in conjunction with other laboratory and clinical findings. EliA SmDP uses the EliA IgG method on the instrument Phadia 2500/5000.
- Eia Smdp ImmunoassayK132631 · Phadia US, Inc. · Aug 29, 2014
- EliA SmDP-SK202067 · Phadia AB · Jul 14, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 31, 2018
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files